Latest Tariff Impact News

Ansell Limited delivered a robust FY25 half-year performance, marked by double-digit sales and earnings growth, successful KBU acquisition integration, and an upward revision of adjusted EPS guidance.

Ansell Limited reports robust FY25 half-year results, driven by strong organic sales and EBIT growth, while accelerating its KBU integration and productivity initiatives.

Fisher & Paykel Healthcare anticipates increased costs from newly imposed US tariffs on imports from Mexico and China, potentially delaying its gross margin recovery timeline but expects no immediate profit impact for FY2025.